COMMITTED TO FIGHTING LIFE-THREATENING RARE DISEASES
TOWARDS A PHARMACOLOGICAL THERAPY FOR ADRENOLEUKODYSTROPHY
NEW HOPE FOR PEOPLE SUFFERING FROM NEURODEGENERATIVE DISEASES
neurometabolic-diseases-ho

ORPHAN CNS DISEASES

Minoryx focuses its research on orphan CNS diseases, a large group of rare diseases affecting the central nervous system

view more >

3D medical background with DNA strands

ADRENOLEUKODYSTROPHY

A rare inherited peroxisomal neurodegenerative disorder, chronically debilitating and life-threatening.

view more >

min-102-home

Min-102

MIN-102 is Minoryx’s candidate for X-linked Adrenoleukodystrophy. It has successfully completed phase 1 clinical trials and is now in phase 2/3.

view more >

 News